Treatment Strategies and Survival Outcomes in Breast Cancer

Contralateral Prophylactic Mastectomy in Women with Unilateral Breast Cancer Who Are Genetic Carriers, Have a Strong Family History or Are just Young at Presentation

(2020) Victoria Teoh et al.   Cancers

HDAC5 Inhibitors as a Potential Treatment in Breast Cancer Affecting Very Young Women

(2020) Sara S. Oltra et al.   Cancers

Cytoplasmic Cyclin E Is an Independent Marker of Aggressive Tumor Biology and Breast Cancer-Specific Mortality in Women over 70 Years of Age

(2020) Simon J. Johnston et al.   Cancers

Impact of Overdiagnosis on Long-Term Breast Cancer Survival

(2019) Jean Fann et al.   Cancers

Cell-Free DNA Variant Sequencing Using CTC-Depleted Blood for Comprehensive Liquid Biopsy Testing in Metastatic Breast Cancer

(2019) Corinna Keup et al.   Cancers

Liver Kinase B1—A Potential Therapeutic Target in Hormone-Sensitive Breast Cancer in Older Women

(2019) Binafsha Manzoor Syed et al.   Cancers

Mastectomy or Breast-Conserving Therapy for Early Breast Cancer in Real-Life Clinical Practice: Outcome Comparison of 7565 Cases

(2019) Stefanie Corradini et al.   Cancers

Why Has Breast Cancer Screening Failed to Decrease the Incidence of de Novo Stage IV Disease?

(2019) Danielle R. Heller et al.   Cancers

Exercise Intervention Improves Clinical Outcomes, but the “Time of Session” is Crucial for Better Quality of Life in Breast Cancer Survivors: A Systematic Review and Meta-Analysis

(2019) Feng Hong et al.   Cancers

Dasatinib Treatment Increases Sensitivity to c-Met Inhibition in Triple-Negative Breast Cancer Cells

(2019) Patricia Gaule et al.   Cancers

Clinical Significance of Lymph-Node Ratio in Determining Supraclavicular Lymph-Node Radiation Therapy in pN1 Breast Cancer Patients Who Received Breast-Conserving Treatment (KROG 14-18): A Multicenter Study

(2019) Jaeho Kim et al.   Cancers

APOBEC3B Gene Expression in Ductal Carcinoma In Situ and Synchronous Invasive Breast Cancer

(2019) Anieta M. Sieuwerts et al.   Cancers

ERCC1 Is a Predictor of Anthracycline Resistance and Taxane Sensitivity in Early Stage or Locally Advanced Breast Cancers

(2019) Tarek M. A. Abdel-Fatah et al.   Cancers

Lactate Dehydrogenase (LDH) Response to First-Line Treatment Predicts Survival in Metastatic Breast Cancer: First Clues for A Cost-Effective and Dynamic Biomarker

(2019) Giacomo Pelizzari et al.   Cancers

Trends in Overall Survival and Treatment Patterns in Two Large Population-Based Cohorts of Patients with Breast and Colorectal Cancer

(2019) Abbema et al.   Cancers

Should All Patients With HR-Positive HER2-Negative Metastatic Breast Cancer Receive CDK 4/6 Inhibitor As First-Line Based Therapy? A Network Meta-Analysis of Data from the PALOMA 2, MONALEESA 2, MONALEESA 7, MONARCH 3, FALCON, SWOG and FACT Trials

(2019) Valentina Rossi et al.   Cancers

Therapy Landscape in Patients with Metastatic HER2-Positive Breast Cancer: Data from the PRAEGNANT Real-World Breast Cancer Registry

(2018) Michael Lux et al.   Cancers